Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter adjusted profit on Friday and indicated that ...

Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter adjusted profit and indicated that its ...

Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine. The financial package will fund the expansion of ...

To say that pharmacy retailer Walgreens Boots Alliance (NASDAQ: WBA) has been struggling would be a massive understatement. It's coming off a horrendous year in 2024, when its share price crashed ...

This was the stock's fifth consecutive day of gains.

WBA's fiscal 2025 first-quarter results are expected to continue to reflect a soft U.S. Retail Pharmacy performance.

The U.S. Justice Department on Friday accused pharmacy chain operator Walgreens Boots Alliance of contributing to the U.S.

Walgreens Boots Alliance surged by >25% today, following strong Q1 2025 earnings and revenue outperformance. Click here to ...

This page uses Cookies. For proper functioning of the page Cookies are needed. You agree to using Cookies by clicking "OK". More infos can be found in our Privacy declaration . If you disagree this ...

Walgreens' worst day of the year came on June 27, when the stock fell 22% on another disappointing earnings report. This time ...

Walgreens Boots Alliance (NASDAQ:WBA) recently reported its fourth-quarter earnings for 2024, revealing a significant decline in its adjusted earnings per share (EPS) by 41% year-over-year to $0.39.